Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
Abstract Cannabis use peaks during adolescence and emerging adulthood, and cannabis use disorder (CUD) is associated with a wide range…
Tom P. Freeman
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use
Abstract Background: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence…
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
Abstract Synthetic cannabinoid receptor agonists (SCRAs) may be used as an alternative to natural cannabis; however, they may carry a…
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study
Abstract Background: Daily use of high-potency cannabis has been reported to carry a high risk for developing a psychotic disorder.…
Supporting Future Cannabis Policy – Developing a Standard Joint Unit: A Brief Back-Casting Exercise
Abstract The standardization of cannabis doses is a priority for research, policy-making, clinical and harm-reduction interventions and consumer security. Scientists…
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Abstract Over the past 5 years, public interest in the potential health benefits of cannabidiol (CBD) has increased exponentially, and…
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence
Abstract Question: Does use of high-potency cannabis (compared with use of low-potency cannabis) increase risks for problems resulting from cannabis…
Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
Abstract Epidemiological and biological evidence support the association between heavy cannabis use and psychosis. However, it is unclear which cannabis…
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Abstract Cannabidiol (CBD) is being investigated as a treatment for several medical disorders but there is uncertainty about its safety.…
The neuropsychopharmacology of cannabis: A review of human imaging studies
Abstract The laws governing cannabis are evolving worldwide and associated with changing patterns of use. The main psychoactive drug in…